Guidelines for Diagnosis and Treatment of Hiv/Aids in China (2005)

Wang Ai-xia,Wang Fu-sheng,Wang Qing-yue,Wang Jian,Feng Tie-jian,Lu Hong-zhou,Sun Hong-qing,Sun Yong-tao,Ye Han-hui,Li Tai-sheng,Li Xing-wang,Liu Zheng-yin,Xing Yu-lan,He Yun,Wang Ning,Wu Hao,Wu Nan-ping,Zhang Fu-jie,Zhou Zeng-quan,Gong En-cong,Zhao Hong-xin,Zhao Min,Tang Xiao-ping,Xu Lian-zhi,Xu Xiao-yuan,Cao Yun-zhen,Kang Lai-yi,Jiang Yan,Cai Wei-Ping,Fan Qing-bo,Pan Xiao-zhang
DOI: https://doi.org/10.1097/00029330-200610010-00002
IF: 6.133
2006-01-01
Chinese Medical Journal
Abstract:Tasked by the Ministry of Health the Chinese Medical Association organized experts to develop these Guidelines for Diagnosis and Treatment of HIV/AIDS. Based on the latest national and international research developments these guidelines adopt an evidence-based approach taking into account the characteristics of Chinas situation. Topics include epidemiology etiology pathogenesis pathological changes clinical presentation and staging laboratory tests diagnosis highly active antiretroviral therapy (HAART) diagnosis and treatment of common opportunistic infections (OIs) prevention of mother-to-child transmission (PMTCT) and post-exposure prophylaxis. Special attention focuses on the antiretroviral therapy. Features of these guidelines include: 1) systematic and comprehensive coverage from basic science to the clinical from treatment to prophylaxis; 2) evidence-based medicine that avoids recommending views and approaches yet to be proven; 3) clinically practical and innovative buildingupon the consensus from Chinese experts (particularly in regard to HIV clinical staging and diagnostic criteria) epidemiology of HIV and AIDS in China and the clinical characteristics of Chinese AIDS patients; 4) recommendation of HAART regimens based on in-country drug availability. (excerpt)
What problem does this paper attempt to address?